SUMMARY:18 F-FDG-PET has been widely used in patients with brain tumors. However, the reported sensitivity and specificity of 18 F-FDG-PET for brain tumor differentiation varied greatly. We performed this meta-analysis to systematically assess the diagnostic performance of 18 F-FDG-PET in differentiating brain tumors. The diagnostic performance of 11 C-methionine PET was assessed for compar-

The shotgun proteomics technique can be applied to screen the proteins with differential expression between hLECs exposed to 1.8 GHz RF and hLECs sham-exposed to 1.8 GHz RF, and three protein biomarkers associated with RF radiation were validated by Western blot assay.